This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Théroux, P. Articles by Juneau, M. Search for Related Content PubMed PubMed Citation Articles by Théroux, P. Articles by Juneau, M.

Intravenous diltiazem in acute myocardial infarction

Diltiazem as adjunctive therapy to activase (DATA) trial

^a Department of Medicine and Department of Radiology, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada

View larger version (12K): [in a new window]   Figure 1 Outline of the investigation performed during the various study periods. 99m-Tc SPECT = technetium-99m sestamibi single emission-computed tomography.

View larger version (20K): [in a new window]   Figure 2 Heart rate and systolic and diastolic blood pressures before and after the intravenous administration of diltiazem or placebo. The standard errors are shown here. bpm = beats per minute. *p < 0.05, p < 0.01, p < 0.001.

View larger version (18K): [in a new window]   Figure 3 Percent cumulative survival without myocardial infarction and without recurrent ischemia (top), and percent cumulative survival without myocardial infarction (bottom) in patients randomized to diltiazem or to placebo.